Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors

Epigenet Insights. 2020 Feb 28:13:2516865720904052. doi: 10.1177/2516865720904052. eCollection 2020.

Abstract

Blood test is a kind of liquid biopsy that checks cancer cells or cancer nucleic acids circulating freely from cells in the blood. A liquid biopsy may be used to distinguish cancer at early stages and it could be a game-changer for both cancer diagnosis and prognosis strategies. Liquid biopsy tests consider several tumor components, such as DNA, RNA, proteins, and the tiny vesicles originating from tumor cells. Actually, liquid biopsy signifies the genetic alterations of tumors through nucleic acids or cells in various body fluids, including blood, urine, cerebrospinal fluid, or saliva in a noninvasive manner. In this review, we present an overall description of liquid biopsy in which circulating tumor cells, cell-free nucleic acids, exosomes, and extrachromosomal circular DNA are included.

Keywords: Liquid biopsy; cell-free nucleic acids (cfNAs); circulating tumor cells (CTCs); exosomes.

Publication types

  • Review